Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Why CVS Health (CVS) Outpaced the Stock Market Today
06:51pm, Friday, 20'th Dec 2024
In the latest trading session, CVS Health (CVS) closed at $44.36, marking a +1.32% move from the previous day.
Varo Bank Introduces Zero Fee Cash Deposits at Participating CVS Locations
01:30pm, Friday, 20'th Dec 2024
New Collaboration with Green Dot Enables Cash Deposits at Over 7,500 CVS Pharmacy Locations AUSTIN, Texas and SAN FRANCISCO , Dec. 20, 2024 /PRNewswire/ -- Varo Bank , the first all-digital nationally
CVS Health has strong position in DOJ case, says TD Cowen
07:05pm, Thursday, 19'th Dec 2024
TD Cowen keeps a Buy rating and $80 price target on CVS. The firm says the DOJ complaint relating to opioid prescriptions is incremental to the 2022 settlement with state and local governments for $5B
CVS accused of billing the U.S. for illegal opioid prescriptions
10:56am, Thursday, 19'th Dec 2024
The U.S. Department of Justice announced a lawsuit against CVS. Transcript: Conway Gittens: There's a rebound on Wall Street Thursday, one-day after stocks suffered their biggest drops since August.
Cramer's Mad Dash: CVS Health
09:46am, Thursday, 19'th Dec 2024
CNBC's Jim Cramer delivers his daily Mad Dash.
Reasons to Ratain CVS Stock in Your Portfolio Now
09:15am, Thursday, 19'th Dec 2024
Investors feel optimistic about CVS Health's 2025 roadmap. Yet, poor macroeconomic conditions are concerning.
CVS contributing to US opioid crisis, Justice Department alleges
08:17am, Thursday, 19'th Dec 2024
CVS Health Corp (NYSE:CVS) has been accused by the US Department of Justice of violating the Controlled Substances Act (CSA) and the False Claims Act (FCA). A lawsuit filed in Rhode Island claims CVS
DOJ Files Complaint in Intervention in Baron & Budd Whistleblower Lawsuit Against CVS Pharmacy
05:07pm, Wednesday, 18'th Dec 2024
WASHINGTON--(BUSINESS WIRE)--Today, the United States Department of Justice (DOJ) announced it has filed a complaint in intervention in a whistleblower lawsuit brought under the False Claims Act (FCA)
US accuses CVS of filling, billing government for illegal opioid prescriptions
03:22pm, Wednesday, 18'th Dec 2024
The U.S. Department of Justice on Wednesday announced a lawsuit accusing CVS of filling and billing federal health insurance programs for illegal opioid prescriptions.
Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy
02:15pm, Wednesday, 18'th Dec 2024
The June/July, 2024 Fortune Magazine revealed 500 biggest U.S. companies by-revenue and profits. Arnold-research focused on 66 December industry-leaders using YCharts 12/13/24 data for Profits from 63
Bert's November 2024 Dividend Income Summary
05:08am, Wednesday, 18'th Dec 2024
We focused on building two positions over the last year: Realty Income and Starbucks. AT&T slashed its dividend several years ago in an effort to shore up its balance sheet. Starbucks has rebounded we
Barclays fact-checked Trump comments on pharmacy benefit managers
01:40pm, Tuesday, 17'th Dec 2024
Barclays analyst Andrew Mok said that while the existential risk to pharmacy benefit managers is low, President-elect Trump's comments yesterday point to additional headline risk and greater support f
UnitedHealth, CVS, and Cigna stock prices take another hit after Trump says he's going to ‘knock out' drug industry middlemen
12:21pm, Tuesday, 17'th Dec 2024
Shares in major healthcare companies fell yesterday after president-elect Donald Trump made comments that he wanted to “knock out” prescription drug industry middlemen. The fall makes this yet ano
CVS's stock seeing worst month in decades as drug seller gets criticism from both parties
11:40am, Tuesday, 17'th Dec 2024
CVS's stock was headed to its biggest monthly loss in 23 years, as Donald Trump vowed to “knock out” the pharmacy middleman.
CVS Health stock price has crashed: buy this dip
03:48am, Tuesday, 17'th Dec 2024
CVS Health (CVS) stock price continued its strong downward trend as the company's woes accelerated. Most recently, it has dropped in the last three consecutive weeks, moving to a low of $46.60, its lo
